DEFA14A ·Filed Apr 27, 2026
Proxy solicitation materials
Actionable Insight • Neutral
No actionable content available from this filing. Monitor future filings for proxy details or a readable definitive proxy statement.
Final — all horizons settled through T+60d ⚠ clustered
VOR ▲ +31.99% at T+60d
NEUTRAL call ✓ call won +31.99% · α vs SPY +28.00% · entry $14.38 → $18.98
T+1d
-1.88%
call -1.88% · α -1.87%
$14.11
settled 5mo ago
T+5d
+2.29%
call +2.29% · α +0.60%
$14.71
settled 5mo ago
T+20d
-1.95%
call -1.95% · α -7.42%
$14.10
settled 4mo ago
T+60d
+31.99%
call +31.99% · α +28.00%
$18.98
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. Vor Biopharma filed a DEFA14A (additional definitive proxy soliciting materials) on April 27, 2026. Without readable content, the specific proposals or solicitation details cannot be assessed.
Key Facts
- Form DEFA14A filed by Vor Biopharma Inc. (VOR) on April 27, 2026
- Filing relates to proxy solicitation materials under Rule 14a-12
- Document content is not readable (binary/encoded)
- Market cap ~$675M; recent insider selling of $41.6M over 30 days
Financial Impact
Not determinable from unavailable content
Risk Factors
- Lack of transparency due to unreadable filing
- Potential material information missed without readable document
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-181892 |
| Document: 0001193125-26-181892-index-headers.html | 0001193125-26-181892 |
| Document: 0001193125-26-181892-index.html | 0001193125-26-181892 |
| Document: 0001193125-26-181892.txt | 0001193125-26-181892 |
9 reports for VOR
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Press Release | $23.37 $23.24 | ▼ −0.58% | ▲ +0.48% | $18.69 (−20.03%) |
Jul 9, 2026 12w ago | 3 | $19.14 $23.67 | ▲ +23.67% | ▲ +21.24% | $18.69 (−2.35%) |
Jun 11, 2026 16w ago | Institutional Cluster | $14.09 $19.75 | ▲ +40.17% | ▲ +38.28% | $18.69 (+32.65%) |
Jun 8, 2026 16w ago | Press Release | $13.29 $20.10 | ▲ +51.24% | ▲ +49.61% | $18.69 (+40.63%) |
May 7, 2026 21w ago | EFFECT | $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | $18.69 (+16.23%) |
Apr 27, 2026 22w ago | S-3 | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.69 (+29.97%) |
Apr 27, 2026 22w ago | DEFA14A | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.69 (+29.97%) |
Mar 27, 2026 27w ago | Press Release | $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | $18.69 (+29.07%) |
Mar 23, 2026 27w ago | Press Release | $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | $18.69 (+53.83%) |
Showing 9 of 9
US Market Status
Market Closed — Opens Mon (38h 32m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access